Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Original Brand Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Prescription Medicine Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Online
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prescription Medicine Market Perspective (2018-2034)
2.2 Prescription Medicine Growth Trends by Region
2.2.1 Global Prescription Medicine Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Prescription Medicine Historic Market Size by Region (2018-2024)
2.2.3 Prescription Medicine Forecasted Market Size by Region (2024-2034)
2.3 Prescription Medicine Market Dynamics
2.3.1 Prescription Medicine Industry Trends
2.3.2 Prescription Medicine Market Drivers
2.3.3 Prescription Medicine Market Challenges
2.3.4 Prescription Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prescription Medicine Players by Revenue
3.1.1 Global Top Prescription Medicine Players by Revenue (2018-2024)
3.1.2 Global Prescription Medicine Revenue Market Share by Players (2018-2024)
3.2 Global Prescription Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prescription Medicine Revenue
3.4 Global Prescription Medicine Market Concentration Ratio
3.4.1 Global Prescription Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Medicine Revenue in 2022
3.5 Prescription Medicine Key Players Head office and Area Served
3.6 Key Players Prescription Medicine Product Solution and Service
3.7 Date of Enter into Prescription Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prescription Medicine Breakdown Data by Type
4.1 Global Prescription Medicine Historic Market Size by Type (2018-2024)
4.2 Global Prescription Medicine Forecasted Market Size by Type (2024-2034)
5 Prescription Medicine Breakdown Data by Application
5.1 Global Prescription Medicine Historic Market Size by Application (2018-2024)
5.2 Global Prescription Medicine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Prescription Medicine Market Size (2018-2034)
6.2 North America Prescription Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Prescription Medicine Market Size by Country (2018-2024)
6.4 North America Prescription Medicine Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prescription Medicine Market Size (2018-2034)
7.2 Europe Prescription Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Prescription Medicine Market Size by Country (2018-2024)
7.4 Europe Prescription Medicine Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prescription Medicine Market Size (2018-2034)
8.2 Asia-Pacific Prescription Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Prescription Medicine Market Size by Region (2018-2024)
8.4 Asia-Pacific Prescription Medicine Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prescription Medicine Market Size (2018-2034)
9.2 Latin America Prescription Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Prescription Medicine Market Size by Country (2018-2024)
9.4 Latin America Prescription Medicine Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prescription Medicine Market Size (2018-2034)
10.2 Middle East & Africa Prescription Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Prescription Medicine Market Size by Country (2018-2024)
10.4 Middle East & Africa Prescription Medicine Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prescription Medicine Introduction
11.1.4 Pfizer Revenue in Prescription Medicine Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Prescription Medicine Introduction
11.2.4 Roche Revenue in Prescription Medicine Business (2018-2024)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Prescription Medicine Introduction
11.3.4 Novartis Revenue in Prescription Medicine Business (2018-2024)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Prescription Medicine Introduction
11.4.4 Johnson & Johnson Revenue in Prescription Medicine Business (2018-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Prescription Medicine Introduction
11.5.4 Merck & Co. Revenue in Prescription Medicine Business (2018-2024)
11.5.5 Merck & Co. Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Prescription Medicine Introduction
11.6.4 Sanofi Revenue in Prescription Medicine Business (2018-2024)
11.6.5 Sanofi Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Prescription Medicine Introduction
11.7.4 AbbVie Revenue in Prescription Medicine Business (2018-2024)
11.7.5 AbbVie Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Prescription Medicine Introduction
11.8.4 GlaxoSmithKline Revenue in Prescription Medicine Business (2018-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Prescription Medicine Introduction
11.9.4 Amgen Revenue in Prescription Medicine Business (2018-2024)
11.9.5 Amgen Recent Development
11.10 Gilead Science
11.10.1 Gilead Science Company Detail
11.10.2 Gilead Science Business Overview
11.10.3 Gilead Science Prescription Medicine Introduction
11.10.4 Gilead Science Revenue in Prescription Medicine Business (2018-2024)
11.10.5 Gilead Science Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Detail
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Prescription Medicine Introduction
11.11.4 Bristol-Myers Squibb Revenue in Prescription Medicine Business (2018-2024)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Prescription Medicine Introduction
11.12.4 AstraZeneca Revenue in Prescription Medicine Business (2018-2024)
11.12.5 AstraZeneca Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Prescription Medicine Introduction
11.13.4 Eli Lilly Revenue in Prescription Medicine Business (2018-2024)
11.13.5 Eli Lilly Recent Development
11.14 Bayer
11.14.1 Bayer Company Detail
11.14.2 Bayer Business Overview
11.14.3 Bayer Prescription Medicine Introduction
11.14.4 Bayer Revenue in Prescription Medicine Business (2018-2024)
11.14.5 Bayer Recent Development
11.15 Novo Nordisk
11.15.1 Novo Nordisk Company Detail
11.15.2 Novo Nordisk Business Overview
11.15.3 Novo Nordisk Prescription Medicine Introduction
11.15.4 Novo Nordisk Revenue in Prescription Medicine Business (2018-2024)
11.15.5 Novo Nordisk Recent Development
11.16 Takeda
11.16.1 Takeda Company Detail
11.16.2 Takeda Business Overview
11.16.3 Takeda Prescription Medicine Introduction
11.16.4 Takeda Revenue in Prescription Medicine Business (2018-2024)
11.16.5 Takeda Recent Development
11.17 Boehringer-Ingelheim
11.17.1 Boehringer-Ingelheim Company Detail
11.17.2 Boehringer-Ingelheim Business Overview
11.17.3 Boehringer-Ingelheim Prescription Medicine Introduction
11.17.4 Boehringer-Ingelheim Revenue in Prescription Medicine Business (2018-2024)
11.17.5 Boehringer-Ingelheim Recent Development
11.18 Allergan
11.18.1 Allergan Company Detail
11.18.2 Allergan Business Overview
11.18.3 Allergan Prescription Medicine Introduction
11.18.4 Allergan Revenue in Prescription Medicine Business (2018-2024)
11.18.5 Allergan Recent Development
11.19 Teva Pharmaceutical Industries
11.19.1 Teva Pharmaceutical Industries Company Detail
11.19.2 Teva Pharmaceutical Industries Business Overview
11.19.3 Teva Pharmaceutical Industries Prescription Medicine Introduction
11.19.4 Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2018-2024)
11.19.5 Teva Pharmaceutical Industries Recent Development
11.20 Mylan
11.20.1 Mylan Company Detail
11.20.2 Mylan Business Overview
11.20.3 Mylan Prescription Medicine Introduction
11.20.4 Mylan Revenue in Prescription Medicine Business (2018-2024)
11.20.5 Mylan Recent Development
11.21 Astellas Pharma
11.21.1 Astellas Pharma Company Detail
11.21.2 Astellas Pharma Business Overview
11.21.3 Astellas Pharma Prescription Medicine Introduction
11.21.4 Astellas Pharma Revenue in Prescription Medicine Business (2018-2024)
11.21.5 Astellas Pharma Recent Development
11.22 Biogen
11.22.1 Biogen Company Detail
11.22.2 Biogen Business Overview
11.22.3 Biogen Prescription Medicine Introduction
11.22.4 Biogen Revenue in Prescription Medicine Business (2018-2024)
11.22.5 Biogen Recent Development
11.23 CSL
11.23.1 CSL Company Detail
11.23.2 CSL Business Overview
11.23.3 CSL Prescription Medicine Introduction
11.23.4 CSL Revenue in Prescription Medicine Business (2018-2024)
11.23.5 CSL Recent Development
11.24 Daiichi Sankyo
11.24.1 Daiichi Sankyo Company Detail
11.24.2 Daiichi Sankyo Business Overview
11.24.3 Daiichi Sankyo Prescription Medicine Introduction
11.24.4 Daiichi Sankyo Revenue in Prescription Medicine Business (2018-2024)
11.24.5 Daiichi Sankyo Recent Development
11.25 Otsuka Holdings
11.25.1 Otsuka Holdings Company Detail
11.25.2 Otsuka Holdings Business Overview
11.25.3 Otsuka Holdings Prescription Medicine Introduction
11.25.4 Otsuka Holdings Revenue in Prescription Medicine Business (2018-2024)
11.25.5 Otsuka Holdings Recent Development
11.26 UCB
11.26.1 UCB Company Detail
11.26.2 UCB Business Overview
11.26.3 UCB Prescription Medicine Introduction
11.26.4 UCB Revenue in Prescription Medicine Business (2018-2024)
11.26.5 UCB Recent Development
11.27 LES LABORATOIRES SERVIER
11.27.1 LES LABORATOIRES SERVIER Company Detail
11.27.2 LES LABORATOIRES SERVIER Business Overview
11.27.3 LES LABORATOIRES SERVIER Prescription Medicine Introduction
11.27.4 LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2018-2024)
11.27.5 LES LABORATOIRES SERVIER Recent Development
11.28 Bausch Health Companies
11.28.1 Bausch Health Companies Company Detail
11.28.2 Bausch Health Companies Business Overview
11.28.3 Bausch Health Companies Prescription Medicine Introduction
11.28.4 Bausch Health Companies Revenue in Prescription Medicine Business (2018-2024)
11.28.5 Bausch Health Companies Recent Development
11.29 Eisai
11.29.1 Eisai Company Detail
11.29.2 Eisai Business Overview
11.29.3 Eisai Prescription Medicine Introduction
11.29.4 Eisai Revenue in Prescription Medicine Business (2018-2024)
11.29.5 Eisai Recent Development
11.30 Abbott Laboratories
11.30.1 Abbott Laboratories Company Detail
11.30.2 Abbott Laboratories Business Overview
11.30.3 Abbott Laboratories Prescription Medicine Introduction
11.30.4 Abbott Laboratories Revenue in Prescription Medicine Business (2018-2024)
11.30.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prescription Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Original Brand Drug
Table 3. Key Players of Generic Drug
Table 4. Global Prescription Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 5. Global Prescription Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Prescription Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Prescription Medicine Market Share by Region (2018-2024)
Table 8. Global Prescription Medicine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Prescription Medicine Market Share by Region (2024-2034)
Table 10. Prescription Medicine Market Trends
Table 11. Prescription Medicine Market Drivers
Table 12. Prescription Medicine Market Challenges
Table 13. Prescription Medicine Market Restraints
Table 14. Global Prescription Medicine Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Prescription Medicine Market Share by Players (2018-2024)
Table 16. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2022)
Table 17. Ranking of Global Top Prescription Medicine Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Prescription Medicine Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prescription Medicine Product Solution and Service
Table 21. Date of Enter into Prescription Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prescription Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Prescription Medicine Revenue Market Share by Type (2018-2024)
Table 25. Global Prescription Medicine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Prescription Medicine Revenue Market Share by Type (2024-2034)
Table 27. Global Prescription Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Prescription Medicine Revenue Market Share by Application (2018-2024)
Table 29. Global Prescription Medicine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Prescription Medicine Revenue Market Share by Application (2024-2034)
Table 31. North America Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America Prescription Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Prescription Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 35. Europe Prescription Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Prescription Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Prescription Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Asia-Pacific Prescription Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Prescription Medicine Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 41. Latin America Prescription Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Prescription Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Prescription Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Middle East & Africa Prescription Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Prescription Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Prescription Medicine Product
Table 49. Pfizer Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Prescription Medicine Product
Table 54. Roche Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Prescription Medicine Product
Table 59. Novartis Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Prescription Medicine Product
Table 64. Johnson & Johnson Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Merck & Co. Company Detail
Table 67. Merck & Co. Business Overview
Table 68. Merck & Co. Prescription Medicine Product
Table 69. Merck & Co. Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 70. Merck & Co. Recent Development
Table 71. Sanofi Company Detail
Table 72. Sanofi Business Overview
Table 73. Sanofi Prescription Medicine Product
Table 74. Sanofi Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. AbbVie Company Detail
Table 77. AbbVie Business Overview
Table 78. AbbVie Prescription Medicine Product
Table 79. AbbVie Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 80. AbbVie Recent Development
Table 81. GlaxoSmithKline Company Detail
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Prescription Medicine Product
Table 84. GlaxoSmithKline Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Amgen Company Detail
Table 87. Amgen Business Overview
Table 88. Amgen Prescription Medicine Product
Table 89. Amgen Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. Gilead Science Company Detail
Table 92. Gilead Science Business Overview
Table 93. Gilead Science Prescription Medicine Product
Table 94. Gilead Science Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 95. Gilead Science Recent Development
Table 96. Bristol-Myers Squibb Company Detail
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Prescription Medicine Product
Table 99. Bristol-Myers Squibb Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. AstraZeneca Company Detail
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Prescription Medicine Product
Table 104. AstraZeneca Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Eli Lilly Company Detail
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Prescription Medicine Product
Table 109. Eli Lilly Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Bayer Company Detail
Table 112. Bayer Business Overview
Table 113. Bayer Prescription Medicine Product
Table 114. Bayer Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 115. Bayer Recent Development
Table 116. Novo Nordisk Company Detail
Table 117. Novo Nordisk Business Overview
Table 118. Novo Nordisk Prescription Medicine Product
Table 119. Novo Nordisk Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 120. Novo Nordisk Recent Development
Table 121. Takeda Company Detail
Table 122. Takeda Business Overview
Table 123. Takeda Prescription Medicine Product
Table 124. Takeda Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 125. Takeda Recent Development
Table 126. Boehringer-Ingelheim Company Detail
Table 127. Boehringer-Ingelheim Business Overview
Table 128. Boehringer-Ingelheim Prescription Medicine Product
Table 129. Boehringer-Ingelheim Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 130. Boehringer-Ingelheim Recent Development
Table 131. Allergan Company Detail
Table 132. Allergan Business Overview
Table 133. Allergan Prescription Medicine Product
Table 134. Allergan Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 135. Allergan Recent Development
Table 136. Teva Pharmaceutical Industries Company Detail
Table 137. Teva Pharmaceutical Industries Business Overview
Table 138. Teva Pharmaceutical Industries Prescription Medicine Product
Table 139. Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 140. Teva Pharmaceutical Industries Recent Development
Table 141. Mylan Company Detail
Table 142. Mylan Business Overview
Table 143. Mylan Prescription Medicine Product
Table 144. Mylan Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 145. Mylan Recent Development
Table 146. Astellas Pharma Company Detail
Table 147. Astellas Pharma Business Overview
Table 148. Astellas Pharma Prescription Medicine Product
Table 149. Astellas Pharma Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 150. Astellas Pharma Recent Development
Table 151. Biogen Company Detail
Table 152. Biogen Business Overview
Table 153. Biogen Prescription Medicine Product
Table 154. Biogen Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 155. Biogen Recent Development
Table 156. CSL Company Detail
Table 157. CSL Business Overview
Table 158. CSL Prescription Medicine Product
Table 159. CSL Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 160. CSL Recent Development
Table 161. Daiichi Sankyo Company Detail
Table 162. Daiichi Sankyo Business Overview
Table 163. Daiichi Sankyo Prescription Medicine Product
Table 164. Daiichi Sankyo Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 165. Daiichi Sankyo Recent Development
Table 166. Otsuka Holdings Company Detail
Table 167. Otsuka Holdings Business Overview
Table 168. Otsuka Holdings Prescription Medicine Product
Table 169. Otsuka Holdings Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 170. Otsuka Holdings Recent Development
Table 171. UCB Company Detail
Table 172. UCB Business Overview
Table 173. UCB Prescription Medicine Product
Table 174. UCB Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 175. UCB Recent Development
Table 176. LES LABORATOIRES SERVIER Company Detail
Table 177. LES LABORATOIRES SERVIER Business Overview
Table 178. LES LABORATOIRES SERVIER Prescription Medicine Product
Table 179. LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 180. LES LABORATOIRES SERVIER Recent Development
Table 181. Bausch Health Companies Company Detail
Table 182. Bausch Health Companies Business Overview
Table 183. Bausch Health Companies Prescription Medicine Product
Table 184. Bausch Health Companies Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 185. Bausch Health Companies Recent Development
Table 186. Eisai Company Detail
Table 187. Eisai Business Overview
Table 188. Eisai Prescription Medicine Product
Table 189. Eisai Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 190. Eisai Recent Development
Table 191. Abbott Laboratories Company Detail
Table 192. Abbott Laboratories Business Overview
Table 193. Abbott Laboratories Prescription Medicine Product
Table 194. Abbott Laboratories Revenue in Prescription Medicine Business (2018-2024) & (US$ Million)
Table 195. Abbott Laboratories Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prescription Medicine Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Prescription Medicine Market Share by Type: 2022 VS 2034
Figure 3. Original Brand Drug Features
Figure 4. Generic Drug Features
Figure 5. Global Prescription Medicine Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Prescription Medicine Market Share by Application: 2022 VS 2034
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Online Case Studies
Figure 10. Others Case Studies
Figure 11. Prescription Medicine Report Years Considered
Figure 12. Global Prescription Medicine Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Prescription Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Prescription Medicine Market Share by Region: 2022 VS 2034
Figure 15. Global Prescription Medicine Market Share by Players in 2022
Figure 16. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Prescription Medicine Revenue in 2022
Figure 18. North America Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Prescription Medicine Market Share by Country (2018-2034)
Figure 20. United States Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Prescription Medicine Market Share by Country (2018-2034)
Figure 24. Germany Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Prescription Medicine Market Share by Region (2018-2034)
Figure 32. China Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Prescription Medicine Market Share by Country (2018-2034)
Figure 40. Mexico Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Prescription Medicine Market Share by Country (2018-2034)
Figure 44. Turkey Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Prescription Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 47. Roche Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 48. Novartis Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 49. Johnson & Johnson Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 50. Merck & Co. Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 51. Sanofi Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 52. AbbVie Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 54. Amgen Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 55. Gilead Science Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 58. Eli Lilly Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 59. Bayer Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 60. Novo Nordisk Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 61. Takeda Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 62. Boehringer-Ingelheim Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 63. Allergan Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 64. Teva Pharmaceutical Industries Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 65. Mylan Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 66. Astellas Pharma Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 67. Biogen Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 68. CSL Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 69. Daiichi Sankyo Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 70. Otsuka Holdings Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 71. UCB Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 72. LES LABORATOIRES SERVIER Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 73. Bausch Health Companies Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 74. Eisai Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 75. Abbott Laboratories Revenue Growth Rate in Prescription Medicine Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed